108 related articles for article (PubMed ID: 4301813)
21. [Growth effect of oxandrolone in patients with Turner's syndrome (author's transl)].
Armendares S; Ramos RM; Navarrete C; Salamanca F
Rev Invest Clin; 1978; 30(4):343-50. PubMed ID: 362499
[No Abstract] [Full Text] [Related]
22. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
[TBL] [Abstract][Full Text] [Related]
23. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM
J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092
[TBL] [Abstract][Full Text] [Related]
24. Oxandrolone for growth promotion in Turner syndrome.
Rosenbloom AL; Frias JL
Am J Dis Child; 1973 Mar; 125(3):385-7. PubMed ID: 4692593
[No Abstract] [Full Text] [Related]
25. Oxandrolone.
Akyurek M; Dunn RM;
Plast Reconstr Surg; 2006 Sep; 118(3):791-4. PubMed ID: 16932191
[No Abstract] [Full Text] [Related]
26. Induction of early puberty in a boy after treatment with oxandrolone?
Doeker B; Müller-Michaels J; Andler W
Horm Res; 1998; 50(1):46-8. PubMed ID: 9691214
[TBL] [Abstract][Full Text] [Related]
27. Studies of anabolic steroids. VI. Effect of prolonged administration of oxandrolone on growth in children and adolescents with gonadal dysgenesis.
Moore DC; Tattoni DS; Ruvalcaba RH; Limbeck GA; Kelley VC
J Pediatr; 1977 Mar; 90(3):462-6. PubMed ID: 190369
[TBL] [Abstract][Full Text] [Related]
28. Anabolic steroids in girls with Turner's syndrome.
Joss EE
Acta Paediatr Scand Suppl; 1988; 343():38-42. PubMed ID: 3057807
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
[TBL] [Abstract][Full Text] [Related]
30. [Comparative action of human growth hormone and synthetic anabolics on the growth rate in hypothalamo-hypophyseal dwarfism].
Royer P; Rappaport R; Elsair J; Ciric S; Cachin O
Ann Endocrinol (Paris); 1970; 31(1):121-30. PubMed ID: 4314692
[No Abstract] [Full Text] [Related]
31. [Growth and skeletal age of girls with gonadal dysgenesis treated with oxandrolone and sex steroids].
Rybakowa M; Sołtysik-Wilk E; Piatkowska E; Surówka K
Folia Med Cracov; 1986; 27(3-4):119-27. PubMed ID: 3570085
[No Abstract] [Full Text] [Related]
32. [Effect of 2 anabolic steroids on "essential" delayed growth].
Canlorbe P; Borniche P; Bader JC
Ann Pediatr (Paris); 1969 Oct; 16(10):582-9. PubMed ID: 4311468
[No Abstract] [Full Text] [Related]
33. Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study).
Zadik Z; Sinai T; Borondukov E; Zung A; Yaniv I; Reifen R
Osteoporos Int; 2005 Sep; 16(9):1036-41. PubMed ID: 15616757
[TBL] [Abstract][Full Text] [Related]
34. Oxandrolone therapy in patients with Turner syndrome.
Urban MD; Lee PA; Dorst JP; Plotnick LP; Migeon CJ
J Pediatr; 1979 May; 94(5):823-7. PubMed ID: 448501
[TBL] [Abstract][Full Text] [Related]
35. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
Gawlik A; Gawlik T; Koehler B; Malecka-Tendera E; Augustyn M; Woska W
Endokrynol Pol; 2005; 56(2):136-44. PubMed ID: 16335681
[TBL] [Abstract][Full Text] [Related]
36. Nitrogen metabolism in growth hormone-deficient children receiving oxandrolone and human growth hormone.
Saeed uz Zafar M; Mellinger RC; Wolf C; Morrow LB; Whitten C; DeJongh D; Hills E
Metabolism; 1974 Mar; 23(3):239-47. PubMed ID: 4591987
[No Abstract] [Full Text] [Related]
37. [Improvement in the longitudinal growth in Ullrich-Turner syndrome with oxandrolone. Function of urinary excretion of steroid hormones].
Schönberger W; Benes P; Morsches B; Zabel B; Scheidt E
Dtsch Med Wochenschr; 1982 Jul; 107(26):1008-11. PubMed ID: 6211346
[TBL] [Abstract][Full Text] [Related]
38. [Growth hormone treatment in short stature of unknown origin].
Wit JM
Tijdschr Kindergeneeskd; 1992 Oct; 60(5):164-72. PubMed ID: 1448806
[TBL] [Abstract][Full Text] [Related]
39. Oxandrolone therapy in six boys with the Prader-Willi syndrome.
Holm VA; Nugent JK; Ruvalcaba RH; Costeff H
J Pediatr; 1989 Feb; 114(2):325-7. PubMed ID: 2915295
[No Abstract] [Full Text] [Related]
40. Use of oxandrolone in Turner syndrome.
Root AW
J Pediatr; 1980 Jan; 96(1):168-9. PubMed ID: 7350303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
